CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.9000
-0.1200 (-11.76%)
At close: Jan 30, 2026, 4:00 PM EST
0.8601
-0.0399 (-4.43%)
After-hours: Jan 30, 2026, 7:59 PM EST
CalciMedica Employees
CalciMedica had 15 employees as of September 30, 2025. The number of employees increased by 2 or 15.38% compared to the same quarter last year.
Employees
15
Change
2
Growth
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,537,333
Market Cap
12.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 15 | 2 | 15.38% |
| Jun 30, 2025 | 15 | 2 | 15.38% |
| Mar 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 14 | 1 | 7.69% |
| Sep 30, 2024 | 13 | -1 | -7.14% |
| Jun 30, 2024 | 13 | -1 | -7.14% |
| Mar 31, 2024 | 13 | 1 | 8.33% |
| Sep 30, 2023 | 14 | 2 | 16.67% |
| Jun 30, 2023 | 14 | 2 | 16.67% |
| Mar 31, 2023 | 12 | 0 | - |
| Sep 30, 2022 | 12 | 0 | - |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioLineRx | 28 |
| Longeveron | 25 |
| Tempest Therapeutics | 21 |
| BioCardia | 20 |
| Moleculin Biotech | 17 |
| Soligenix | 16 |
| Sensei Biotherapeutics | 15 |
| Cocrystal Pharma | 11 |
CALC News
- 4 days ago - CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - Benzinga
- 4 days ago - CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation - PRNewsWire
- 2 months ago - CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire
- 2 months ago - CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension - PRNewsWire
- 2 months ago - CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 - PRNewsWire
- 3 months ago - CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ - PRNewsWire
- 5 months ago - CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
- 6 months ago - CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire